Financial Summary (All financials)
| In millions, except per share items | Dec-31-22 | Dec-31-21 | Dec-31-20 | Dec-31-19 |
| Revenues | 0.0 | 0.0 | 0.0 | 0.0 |
| Cost of goods sold | 0.0 | 0.0 | 0.0 | 0.0 |
| Gross profit | 0.0 | 0.0 | 0.0 | 0.0 |
| Research and development | 87.8 | 69.0 | 32.6 | 25.1 |
| General and administrative | 31.0 | 23.6 | 10.7 | 7.0 |
| EBIT | -119.7 | -93.3 | -43.6 | -32.1 |
| Pre-tax income | -104.2 | -86.8 | -41.7 | -33.6 |
| Income taxes | 0.0 | 0.0 | 0.0 | 0.0 |
| Tax rate | 0.0% | 0.0% | 0.0% | 0.0% |
| Net income | -104.2 | -86.8 | -41.7 | -33.6 |
| |
| Diluted EPS | ($0.48) | ($0.44) | ($0.43) | ($162.34) |
| Shares outstanding (diluted) | 216.7 | 197.9 | 97.5 | 0.2 |
| |
| EBIT is a non-GAAP figure that excludes all non-recurring expenses: restructuring costs, asset impairments, IPR&D writeoffs, and other unusual charges. |
|